Improved safety and efficacy of a second-generation diphtheria toxin-based fusion protein Feb. 28, 2019
Sarepta Therapeutics announces preliminary results from first cohort in phase I/II study of MYO-101 Feb. 28, 2019
Generation of a novel nucleoside inhibitor for the treatment of ischemia-reperfusion injury Feb. 28, 2019
RSS